FFCP PHASE1:Mm9::chrX:160480258..160480272,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=595|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chrX:160480258..160480272,-|id=chrX:160480258..160480272,-|ontology_enrichment_celltype=CL:0000764!9.40e-10!3;CL:0000765!9.40e-10!3;CL:0000038!9.40e-10!3;CL:0000547!9.40e-10!3|ontology_enrichment_celltype_v019_2=CL:0000764,1.33e-65,3;CL:0000765,1.33e-65,3;CL:0000038,1.33e-65,3;CL:0000547,1.33e-65,3;CL:0000050,1.19e-22,9;CL:0000839,5.32e-16,13;CL:0000763,3.50e-13,16;CL:0000049,3.01e-11,19;CL:0002031,9.29e-09,25;CL:0002610,1.88e-08,3;CL:0000988,5.08e-07,32;CL:0002032,5.08e-07,32;CL:0000037,5.08e-07,32;CL:0000837,5.08e-07,32|ontology_enrichment_disease=DOID:2531!9.40e-10!3;DOID:0060083!9.40e-10!3;DOID:1240!9.40e-10!3|ontology_enrichment_disease_v019_2=DOID:2531,1.33e-65,3;DOID:0060083,1.33e-65,3;DOID:1240,1.33e-65,3;DOID:0050686,2.03e-33,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0004684,1.88e-08,3;UBERON:0002275,1.88e-08,3|phase1_expression=0,0,0,0,0,0.16787927191189,0.233612640595526,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0850432901510698,0,0,0,0,0,0,0,0,0,0,79.3788341824539,72.5776449349793,47.5445043046316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.515672092277442,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.10115880999389,0.127687338085188,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117588707135705,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.149790639404823,0.915001205637253,0,0,0.511430914660661,0,0.324482526135515,0,0,0,0,0,0,0,0,0.0680364991513279,0,0.187403449119458,0,0,0,0.175951124163949,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.210289948564127,0,0,0,0,0,0,0,0.22237804384487,0,0,0,0,0,0,0,0,0,0,0,0,0,0.193952487167626,0.140271639780637,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0603129249281559,0,0,0,0,0,0,0,0,0,0,0,0,0,0.954670618015114,0,0,0,0,0,0,0,0,0,0,0,0,0.165458490457098,0.194451188344048,0,0,0,0,0,0,0,0,0,0.102710957164827,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.564751842617067,0.460325236507177,0,0.343706364687375,0,0.755393897389701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.145346416632329,0,0,0.182927972872773,0,0,0,0,0,0,0,0.192906610981141,0.249810577937946,0,0,0,0,0|short_description=p@chrX:160480258..160480272,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=595 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chrX:160480258..160480272,- | |||
|description=CAGE_peak_at_chrX:160480258..160480272,- | |||
|id=chrX:160480258..160480272,- | |||
|ontology_enrichment_celltype=CL:0000764!9.40e-10!3;CL:0000765!9.40e-10!3;CL:0000038!9.40e-10!3;CL:0000547!9.40e-10!3 | |||
|ontology_enrichment_celltype_v019_2=CL:0000764,1.33e-65,3;CL:0000765,1.33e-65,3;CL:0000038,1.33e-65,3;CL:0000547,1.33e-65,3;CL:0000050,1.19e-22,9;CL:0000839,5.32e-16,13;CL:0000763,3.50e-13,16;CL:0000049,3.01e-11,19;CL:0002031,9.29e-09,25;CL:0002610,1.88e-08,3;CL:0000988,5.08e-07,32;CL:0002032,5.08e-07,32;CL:0000037,5.08e-07,32;CL:0000837,5.08e-07,32 | |||
|ontology_enrichment_disease=DOID:2531!9.40e-10!3;DOID:0060083!9.40e-10!3;DOID:1240!9.40e-10!3 | |||
|ontology_enrichment_disease_v019_2=DOID:2531,1.33e-65,3;DOID:0060083,1.33e-65,3;DOID:1240,1.33e-65,3;DOID:0050686,2.03e-33,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0004684,1.88e-08,3;UBERON:0002275,1.88e-08,3 | |||
|phase1_expression=0,0,0,0,0,0.16787927191189,0.233612640595526,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0850432901510698,0,0,0,0,0,0,0,0,0,0,79.3788341824539,72.5776449349793,47.5445043046316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.515672092277442,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.10115880999389,0.127687338085188,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117588707135705,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.149790639404823,0.915001205637253,0,0,0.511430914660661,0,0.324482526135515,0,0,0,0,0,0,0,0,0.0680364991513279,0,0.187403449119458,0,0,0,0.175951124163949,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.210289948564127,0,0,0,0,0,0,0,0.22237804384487,0,0,0,0,0,0,0,0,0,0,0,0,0,0.193952487167626,0.140271639780637,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0603129249281559,0,0,0,0,0,0,0,0,0,0,0,0,0,0.954670618015114,0,0,0,0,0,0,0,0,0,0,0,0,0.165458490457098,0.194451188344048,0,0,0,0,0,0,0,0,0,0.102710957164827,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.564751842617067,0.460325236507177,0,0.343706364687375,0,0.755393897389701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.145346416632329,0,0,0.182927972872773,0,0,0,0,0,0,0,0.192906610981141,0.249810577937946,0,0,0,0,0 | |||
|short_description=p@chrX:160480258..160480272,- | |||
}} |
Latest revision as of 04:00, 6 August 2015
Short description: | p@chrX:160480258..160480272, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chrX:160480258..160480272, - |
Coexpression cluster: | MCL_coexpression_mm9:595 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
erythroid lineage cell | 1.33e-65 | 3 |
erythroblast | 1.33e-65 | 3 |
erythroid progenitor cell | 1.33e-65 | 3 |
proerythroblast | 1.33e-65 | 3 |
megakaryocyte-erythroid progenitor cell | 1.19e-22 | 9 |
myeloid lineage restricted progenitor cell | 5.32e-16 | 13 |
myeloid cell | 3.50e-13 | 16 |
common myeloid progenitor | 3.01e-11 | 19 |
hematopoietic lineage restricted progenitor cell | 9.29e-09 | 25 |
raphe nuclei neuron | 1.88e-08 | 3 |
hematopoietic cell | 5.08e-07 | 32 |
hematopoietic oligopotent progenitor cell | 5.08e-07 | 32 |
hematopoietic stem cell | 5.08e-07 | 32 |
hematopoietic multipotent progenitor cell | 5.08e-07 | 32 |
Ontology term | p-value | n |
---|---|---|
raphe nuclei | 1.88e-08 | 3 |
reticular formation | 1.88e-08 | 3 |
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 1.33e-65 | 3 |
immune system cancer | 1.33e-65 | 3 |
leukemia | 1.33e-65 | 3 |
organ system cancer | 2.03e-33 | 6 |